PURPOSE OF THE RESEARCH: To compare the psychological health and quality of life (QoL) of women with breast cancer, and to determine the relationship between anxiety, depression and QoL during treatment and one year afterwards. METHODS AND SAMPLE: For this secondary analysis, 269 women undergoing adjuvant therapy for breast cancer, and 148 women with breast cancer who had completed all treatment within the last year completed a self-report questionnaire covering the Hospital Anxiety and Depression Scale-Cantonese/Chinese version, Functional Assessment of Cancer Therapy-General, and demographic and clinical characteristics. KEY RESULTS: The ongoing-therapy group showed higher levels of anxiety and depression and lower levels of all QoL dimensions than the post-therapy group. Linear regression results showed that both anxiety and depression were significantly related to physical and functional well-being, while depression was associated with social/family well-being in both groups. In the case of emotional well-being, anxiety had a strong significant association in both groups and depression a significant relationship only in the ongoing-therapy group. CONCLUSIONS: The psychological health of women with breast cancer is affected during and after treatment. Psychological distress in these patients, including anxiety and depression, has independent associations with impaired emotional, functional, physical and social well-being. The results highlight the importance of timely detection of anxiety and depression, and their proper management, during the treatment and survivorship phases of the breast cancer trajectory.
PURPOSE OF THE RESEARCH: To compare the psychological health and quality of life (QoL) of women with breast cancer, and to determine the relationship between anxiety, depression and QoL during treatment and one year afterwards. METHODS AND SAMPLE: For this secondary analysis, 269 women undergoing adjuvant therapy for breast cancer, and 148 women with breast cancer who had completed all treatment within the last year completed a self-report questionnaire covering the Hospital Anxiety and Depression Scale-Cantonese/Chinese version, Functional Assessment of Cancer Therapy-General, and demographic and clinical characteristics. KEY RESULTS: The ongoing-therapy group showed higher levels of anxiety and depression and lower levels of all QoL dimensions than the post-therapy group. Linear regression results showed that both anxiety and depression were significantly related to physical and functional well-being, while depression was associated with social/family well-being in both groups. In the case of emotional well-being, anxiety had a strong significant association in both groups and depression a significant relationship only in the ongoing-therapy group. CONCLUSIONS: The psychological health of women with breast cancer is affected during and after treatment. Psychological distress in these patients, including anxiety and depression, has independent associations with impaired emotional, functional, physical and social well-being. The results highlight the importance of timely detection of anxiety and depression, and their proper management, during the treatment and survivorship phases of the breast cancer trajectory.
Authors: Victoria Wittmann; Melinda Látos; Zoltán Horváth; Zsolt Simonka; Attila Paszt; György Lázár; Márta Csabai Journal: Qual Life Res Date: 2017-03-29 Impact factor: 4.147
Authors: Syarifah Maisarah Syed Alwi; Vairavan Narayanan; Nur Aishah Mohd Taib; Normah Che Din Journal: Support Care Cancer Date: 2021-11-29 Impact factor: 3.603
Authors: Andrea A Cohee; Timothy Stump; Rebecca N Adams; Shelley A Johns; Diane Von Ah; Kathleen Zoppi; Betsy Fife; Patrick O Monahan; David Cella; Victoria L Champion Journal: Qual Life Res Date: 2016-02-16 Impact factor: 4.147
Authors: Chong Guan Ng; Salina Mohamed; Mee Hoong See; Faizah Harun; Maznah Dahlui; Ahmad Hatim Sulaiman; Nor Zuraida Zainal; Nur Aishah Taib Journal: Health Qual Life Outcomes Date: 2015-12-30 Impact factor: 3.186